We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 447

EEOC proposes regulations on wellness program compliance with the ADA

  • Hogan Lovells
  • -
  • USA
  • -
  • April 17 2015

The U.S. Equal Employment Opportunity Commission (EEOC) announced yesterday that it will issue proposed regulations on Monday, April 20, to clarify

New FDA draft guidance on medical device panel meetings generally confirms current practices, provides additional detail

  • Hogan Lovells
  • -
  • USA
  • -
  • April 10 2015

On April 1, 2015 the Food and Drug Administration (FDA) released a draft guidance document discussing procedures for Medical Device Advisory Committee

Outlook for 2015: antitrust litigation in the pharma industrymore than just Actavis progeny

  • Hogan Lovells
  • -
  • USA
  • -
  • March 19 2015

In 2014 there were a number of significant antitrust developments for the pharmaceutical industry. These involved not only pharmaceutical patent

Supreme Court overturns paralyzed veterans doctrine; more changes in administrative law to follow?

  • Hogan Lovells
  • -
  • USA
  • -
  • March 16 2015

On March 9, the Supreme Court issued its ruling in Perez v. Mortgage Bankers Association. The decision that may not have seized headlines, but it has

CMS Innovation Center announces Next Generation ACO Model

  • Hogan Lovells
  • -
  • USA
  • -
  • March 13 2015

On March 10, 2015, the CMS Innovation Center (CMMI) announceda new model, the Next Generation ACO Model. This newest model builds on experience from

King v. Burwell: a report following oral argument before the Supreme Court

  • Hogan Lovells
  • -
  • USA
  • -
  • March 5 2015

In King v. Burwell, the Supreme Court will decide whether the federal government has the authority to make subsidies available to millions of

CMS Innovation Center announces new initiative to encourage better oncology care

  • Hogan Lovells
  • -
  • USA
  • -
  • March 4 2015

Today, the CMS Innovation Center posted the transcript for awebinar announcing a new innovation model which creates incentives to furnish efficient

FDA publishes draft guidances and memorandum of understanding on drug compounding and repackaging

  • Hogan Lovells
  • -
  • USA
  • -
  • February 23 2015

On February 13, 2015, FDA issued four draft guidance documents and a draft memorandum of understanding (MOU) regarding the compounding of drug and

FDA authorizes 23andMe to market DTC genetic carrier test, and announces plan to exempt certain carrier screening testing from premarket review

  • Hogan Lovells
  • -
  • USA
  • -
  • February 23 2015

On February 19, 2015, the U.S. Food and Drug Administration (FDA or the Agency) authorized for marketing 23andMe's Bloom Syndrome carrier test, a

FDA announces major proposed rule amending Hatch-Waxman regulations

  • Hogan Lovells
  • -
  • USA
  • -
  • February 13 2015

On February 6, 2015, the Food and Drug Administration (FDA) published in the Federal Register (FR) a comprehensive proposed rule (80 FR 6802) to